Progress of immunosuppressant management, infection prevention and treatment after liver transplantation in severe liver disease
10.3969/j.issn.1674-7445.2020.03.004
- VernacularTitle:危重症肝病肝移植术后免疫抑制剂管理和感染的防治进展
- Author:
Han LI
1
;
Yanan JIA
;
Qiang HE
;
Xianliang LI
Author Information
1. Department of Hepatobiliary-pancreatic-splenic Surgery, Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China
- Publication Type:Research Article
- Keywords:
Liver transplantation;
Liver failure;
Severe liver disease;
Multiple organ failure;
Hepatic encephalopathy;
Infection;
Immunosuppressant;
Multi-drug resistant bacteria
- From:
Organ Transplantation
2020;11(3):344-
- CountryChina
- Language:Chinese
-
Abstract:
Liver transplantation is an effective treatment of severe liver disease. However, the pathophysiological changes of patients with severe liver disease are complicated, which significantly increase the difficulty of perioperative management of liver transplantation. Therefore, it is of great significance to strengthen postoperative management of the recipients with severe liver disease after liver transplantation. In this article, the pathophysiological characteristics of severe liver disease, the selection of immunosuppressant after liver transplantation, and the prevention and treatment of infection after liver transplantation in patients with severe liver disease were summarized.
